Search research articles
Contact Us
Filters
Showing results (171-180 of 180) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 180 results.
Thorax
|
December 10, 2023
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease
Tracy J Doyle, Pierre-Antoine Juge, Anna L Peljto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 9, 2021
Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti-Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis
Yuko Okamoto, Stephanie Devoe, Nickie Seto, et al.
The Lancet. Respiratory Medicine
|
June 5, 2026
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement
Joshua J Solomon, Philippe Dieudé, Scott M Matson, et al.
Ebiomedicine
|
April 7, 2019
Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients
Judith A James, Hua Chen, Kendra A Young, et al.
Arthritis Research & Therapy
|
May 9, 2020
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Yun-Jeong Song, In Ah Choi, Françoise Meylan, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Multi-lineage transcriptional and cell communication signatures define pathways in individuals at-risk for developing rheumatoid arthritis that initiate and perpetuate disease
Cong Liu, E Barton Prideaux, Peiyao Wu, et al.
Nature Communications
|
November 22, 2023
Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis
Eddie A James, V Michael Holers, Radhika Iyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Kevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Systemic inflammation and lymphocyte activation precede rheumatoid arthritis
Ziyuan He, Marla C Glass, Pravina Venkatesan, et al.
Science Translational Medicine
|
September 24, 2025
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation
Ziyuan He, Marla C Glass, Pravina Venkatesan, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 180) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 180 results.
Thorax
|
December 10, 2023
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease
Tracy J Doyle, Pierre-Antoine Juge, Anna L Peljto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 9, 2021
Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti-Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis
Yuko Okamoto, Stephanie Devoe, Nickie Seto, et al.
The Lancet. Respiratory Medicine
|
June 5, 2026
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement
Joshua J Solomon, Philippe Dieudé, Scott M Matson, et al.
Ebiomedicine
|
April 7, 2019
Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients
Judith A James, Hua Chen, Kendra A Young, et al.
Arthritis Research & Therapy
|
May 9, 2020
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Yun-Jeong Song, In Ah Choi, Françoise Meylan, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Multi-lineage transcriptional and cell communication signatures define pathways in individuals at-risk for developing rheumatoid arthritis that initiate and perpetuate disease
Cong Liu, E Barton Prideaux, Peiyao Wu, et al.
Nature Communications
|
November 22, 2023
Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis
Eddie A James, V Michael Holers, Radhika Iyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Kevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Systemic inflammation and lymphocyte activation precede rheumatoid arthritis
Ziyuan He, Marla C Glass, Pravina Venkatesan, et al.
Science Translational Medicine
|
September 24, 2025
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation
Ziyuan He, Marla C Glass, Pravina Venkatesan, et al.
Page
of 18